Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Guangzhao Qi"'
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Polymyxin B has been used as a last-line therapy for the treatment of carbapenem-resistant gram-negative bacterial infection. The pharmacokinetic/pharmacodynamic index (AUC/MIC) of polymyxin B has not been clinically evaluated, given that the broth m
Externí odkaz:
https://doaj.org/article/b3f8bb77c4c144bda3dbb418d5a4e93f
Autor:
Chong Li, Jingyi Li, Chao Han, Ting Wang, Lixia Zhang, Zhifang Wang, Tingting Wang, Lijun Xu, Guangzhao Qi, Guijun Qin, Xialian Li, Lili Zheng
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Background: Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors arising from chromaffin cells in the adrenal medulla and extra-adrenal ganglia, respectively. The study was aimed to investigate the clinical and genetic characteris
Externí odkaz:
https://doaj.org/article/00a5582959c94604b5a31857c937d39b
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Inter-individual differences of drug responses could be attributed to genetic variants of pharmacogenes such as cytochrome P450 (CYP), phase 2 enzymes, and transporters. In contrast to extensive studies on the genetic polymorphisms of CYP ge
Externí odkaz:
https://doaj.org/article/8aaecce1c52a46daa08aede5d1ff68f8
Autor:
Chongzhen Qin, Menglin Wu, Xinru Wang, Wenda Zhang, Guangzhao Qi, Na-Yi Wu, Xiaoting Liu, Yaoyao Lu, Jingmin Zhang, Yuna Chai
Publikováno v:
PeerJ, Vol 10, p e13148 (2022)
Our study aims to explore the active components and mechanisms of the Danshen-Guizhi drug pair in treating ovarian cancer by network pharmacology and in vitro experiment. The “component-target-pathway” diagram of the Danshen-Guizhi drug pair was
Externí odkaz:
https://doaj.org/article/72d82b328b4a4e99a6e57019006d62ca
Autor:
Weijie Wang, Guangzhao Qi, Xiangtian Zhao, Yanping Zhang, Rongtao Zhu, Ruopeng Liang, Yuling Sun
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveLittoral cell angioma (LCA) is currently considered to be a rare splenic tumor with malignant potential. As the epidemiology, pathogenesis, clinical manifestation, treatment, and prognosis remain unclear, the clinical diagnosis and treatment
Externí odkaz:
https://doaj.org/article/1b3a574cd93340ea9988f8384bd1f530
Autor:
Jingmin Zhang, Guangzhao Qi, Chao Han, Yubing Zhou, Yongjie Yang, Xinru Wang, Suna Liu, Xiaojian Zhang
Publikováno v:
Pharmacogenomics and Personalized Medicine
Jingmin Zhang,1,2 Guangzhao Qi,1,2 Chao Han,1,2 Yubing Zhou,1,2 Yongjie Yang,1 Xinru Wang,1,2 Suna Liu,3 Xiaojian Zhang1,2 1Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Peopleâs Republic of China; 2He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dc596d239b61e637b062fa0763da888
https://doi.org/10.2147/pgpm.s338198
https://doi.org/10.2147/pgpm.s338198
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 49:219-227
Over 50% prescribed drugs are metabolised by cytochrome P450 3A (CYP3A) and glutathione S-transferase pi (GSTP1) adds a glutathione to the oxidative products by CYP3A, which increases the hydrophilic property of metabolites and facilitates the excret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f5390153d4e82c4a007671ccf08532a
https://doi.org/10.1111/1440-1681.13604
https://doi.org/10.1111/1440-1681.13604
Autor:
Min Li, Guangzhao Qin, Chen Jia, Danyu Zhang, Zhikang Li, Xiangguang Han, Shusheng Xu, Libo Zhao, Guoxi Luo, Cunlang Liu, Ping Yang, Qijing Lin
Publikováno v:
Microsystems & Nanoengineering, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract With the rapid development of various fields, including aerospace, industrial measurement and control, and medical monitoring, the need to quantify flow velocity measurements is increasing. It is difficult for traditional flow velocity senso
Externí odkaz:
https://doaj.org/article/f68d6bcb78e14ba2a2f9365c140f979b
Publikováno v:
Endoscopy. 55:E131-E132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e4ffc563be3fb3f7c7e2f1624cbefd
https://doi.org/10.1055/a-1937-9836
https://doi.org/10.1055/a-1937-9836
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(11)
The risk of ticagrelor-related bleeding events remains a major clinical concern, especially in East Asian populations. Previous studies have reported higher ticagrelor exposure in Asian patients than in Caucasians. This prompted us to investigate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7309faa1547071400a6fda062ce4388
https://pubmed.ncbi.nlm.nih.gov/35644848
https://pubmed.ncbi.nlm.nih.gov/35644848